{"id":192,"date":"2021-05-11T00:00:49","date_gmt":"2021-05-10T15:00:49","guid":{"rendered":"https:\/\/www.dna-chip.co.jp\/news\/?p=192"},"modified":"2021-11-05T13:22:47","modified_gmt":"2021-11-05T04:22:47","slug":"20210511","status":"publish","type":"post","link":"https:\/\/www.dna-chip.co.jp\/news\/press\/20210511\/","title":{"rendered":"ASBrS 2021\u3000\u30a2\u30e1\u30ea\u30ab\u4e73\u817a\u5916\u79d1\u5b66\u4f1avirtual symposium \u8996\u8074\u52d5\u753b\u306e\u3054\u6848\u5185"},"content":{"rendered":"<p>2021\u5e744\u670830\u65e5\u306b\u7b2c22\u56de\u7c73\u56fd\u7c73\u56fd\u4e73\u817a\u5916\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u958b\u50ac\u3055\u308c\u307e\u3057\u305f\u3001Agendia\u793e\u4e3b\u50acvirtual symposium\u306eMammaprint\u3068BluePrint\u306b\u95a2\u3059\u308b\u767a\u8868\u306b\u3064\u304d\u307e\u3057\u3066\u52d5\u753b\u8996\u8074\u3092\u3054\u6848\u5185\u3044\u305f\u3057\u307e\u3059\u3002<br \/>\n  \u767b\u9332\u4e0d\u8981\u3067\u3054\u89a7\u3044\u305f\u3060\u304f\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<div>\n<p> \u30bf\u30a4\u30c8\u30eb<br \/>\n    A Case-Based Discussion of Integrating MammaPrint and BluePrint into  Treatment Planning for Patients with Early Stage Breast Cancer <\/p>\n<p> \u767a\u8868\u6982\u8981<br \/>\n    \u4e0b\u8a182\u540d\u306b\u3088\u308a\u3001\u75c7\u4f8b\u63d0\u793a\u3092\u884c\u3044\u306a\u304c\u3089\u65e9\u671f\u4e73\u764c\u306b\u304a\u3051\u308b\u30b5\u30d6\u30bf\u30a4\u30d4\u30f3\u30b0\u5225\u306e\u6cbb\u7642\u65b9\u91dd\u306b\u3064\u3044\u3066\u6700\u65b0\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u7d39\u4ecb\u3084\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304c\u884c\u308f\u308c\u307e\u3057\u305f\u3002<br \/>\n    \u3000Dr. Pat Whitworth \uff08\u4e73\u817a\u5916\u79d1\u533b\u3001Nashville Breast Center\u3001NBRST\u8a66\u9a13\u203b\u306e\u4e3b\u4efb\u7814\u7a76\u8005\uff09<br \/>\n    \u3000Dr. William Audeh\uff08\u4e73\u817a\u816b\u760d\u5185\u79d1\u533b\u3001Agendia\u793e Chief Medical Officer\uff09\n  <\/p>\n<p> \u672c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3067\u306f\u3001MammaPrint\u306eultra-low risk\u306b\u304a\u3051\u308b\u30db\u30eb\u30e2\u30f3\u7642\u6cd5\u306e\u6295\u4e0e  \u671f\u9593\u77ed\u7e2e\u306e\u6cbb\u7642\u65b9\u91dd\u3084\u3001BluePrint\u306b\u3088\u308aER+\u3067MammaPrint high-risk\u75c7\u4f8b\u306e\u7d04 30\uff05\u306e\u75c7\u4f8b\u306b\u3064\u3044\u3066Basal  type\u3068\u306e\u60c5\u5831\u304c\u5f97\u3089\u308c\u308b\u3053\u3068\u3067\u3069\u306e\u3088\u3046\u306b\u60a3\u8005\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8 \u306b\u3064\u306a\u304c\u308b\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u3067\u304d\u308b\u304b\u3001\u65b0\u898f\u30ec\u30b8\u30e1\u30f3\u958b\u767a\u304c\u53ef\u80fd\u306b\u306a\u308b\u304b\u7b49\u306b\u3064\u3044\u3066  \u30a8\u30d3\u30c7\u30f3\u30b9\u7d39\u4ecb\u304a\u3088\u3073\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304c\u884c\u308f\u308c\u3066\u304a\u308a\u307e\u3059\u3002 <\/p>\n<p> ASBrS Breakfast Symposia April 30th<br \/>\n    \u8996\u8074\u5148URL\uff1a<a href=\"https:\/\/p.allego.com\/UFl-2KxzE-5V\" target=\"_blank\">https:\/\/p.allego.com\/UFl-2KxzE-5V<\/a><\/p>\n<p> \u203bNBRST\u8a66\u9a13\uff1aNeoadjuvant Breast Registry Symphony Trial<br \/>\n    MammaPrint\u3001BluePrint\u306b\u3088\u308b\u5206\u5b50\u30b5\u30d6\u30bf\u30a4\u30d4\u30f3\u30b0\u3068IHC \/ FISH\u3067\u306e\u30b5\u30d6\u30bf\u30a4\u30d4\u30f3\u30b0\u306b\u3088\u308b\u3001NAC\/NET\u306epCR\u7387\u304a\u3088\u3073\u9577\u671f\u4e88\u5f8c\u3092\u691c\u8a3c\u3059\u308b\u524d\u5411\u304d\u30ec\u30b8\u30b9\u30c8\u30ea\u8a66\u9a13\u3002<br \/>\n    Ann Sur Onc\u306e\u8ad6\u6587\u3001SABCS2020\u30dd\u30b9\u30bf\u306f\u30fc<a href=\"https:\/\/agendia.com\/landmark-trials\/#NBRST\" target=\"_blank\">\u3053\u3061\u3089<\/a>\u304b\u3089\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u53ef\u80fd\u3067\u3059\u3002<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2021\u5e744\u670830\u65e5\u306b\u7b2c22\u56de\u7c73\u56fd\u7c73\u56fd\u4e73\u817a\u5916\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u958b\u50ac\u3055\u308c\u307e\u3057\u305f\u3001Agendia\u793e\u4e3b\u50acvirtual symposium\u306eMammaprint\u3068BluePrint\u306b\u95a2\u3059\u308b\u767a\u8868\u306b\u3064\u304d\u307e\u3057\u3066\u52d5\u753b\u8996\u8074\u3092\u3054\u6848\u5185\u3044\u305f\u3057\u307e [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3,13],"tags":[],"class_list":["post-192","post","type-post","status-publish","format-standard","hentry","category-press","category-mammaprint"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/posts\/192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/comments?post=192"}],"version-history":[{"count":2,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/posts\/192\/revisions"}],"predecessor-version":[{"id":194,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/posts\/192\/revisions\/194"}],"wp:attachment":[{"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/media?parent=192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/categories?post=192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dna-chip.co.jp\/news\/wp-json\/wp\/v2\/tags?post=192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}